Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04273113
Other study ID # RG_17-105
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 11, 2017
Est. completion date March 28, 2020

Study information

Verified date September 2019
Source University of Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

14 participants residing in a forensic psychiatric hospital completed 15 Heart Rate Variance (HRV) biofeedback sessions. They completed 4 psychometric questionnaires, pre, during and post biofeedback training.


Description:

This study aimed to establish whether Heart Rate Variance (HRV) biofeedback improved HRV coherence as well as psychological well-being (depression, anxiety, emotion regulation, and mindfulness) over the course of 15 biofeedback sessions in a sample of 14 patients with varying diagnoses; Paranoid Schizophrenia, Schizoaffective Disorder, Personality Disorder or Mixed Diagnosis. All 14 participants (n=10 male, n=4 female) participated in 15 biofeedback sessions. The study was researched and treatment was facilitated by a trainee forensic psychologist working with both male and female offenders residing within a Forensic Psychiatric Hospital, on both low and medium secure wards. An average coherence percentage was captured using the Wild Devine Programme® Relaxing Rhythms software for each session. Quantitative data were collected and analysed before, during and after biofeedback treatment to assess whether there was improvement in psychometric measures of depression, anxiety, emotion regulation and facets of mindfulness. A quasi experimental 'A-B-A design' was employed to assess the research questions.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 14
Est. completion date March 28, 2020
Est. primary completion date April 27, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 77 Years
Eligibility Inclusion Criteria:

- Male and female offenders aged 18 and above.

- Male and female offenders who reside in a medium and low Forensic Psychiatric Hospital.

- Individuals who have the capacity to consent to take part in the research

- Individuals deemed mentally stable and were found to have capacity to consent by their Multi-Disciplinary Team (MDT).

Exclusion Criteria:

- Individuals under the age of 18.

- Individuals who are not detained in a Forensic Psychiatric Hospital.

- Individuals deemed not well enough to consent by their Multi-Disciplinary Team (MDT).

- A level of cognitive impairment determined by diagnosis that would prevent individuals from understanding the feedback obtained. via pictorial or verbal prompts

- Individuals with specific breathing difficulties (e.g., chronic obstructive pulmonary disease) that would restrict them from being able to practice the breathing techniques.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Difficulties in Emotional Regulation Scale, Five Facet Mindfulness Questionnaire, Becks Depression and Becks Anxiety
Patients asked to complete these 4 questionnaires pre, during and post biofeedback training
Behavioral:
HRV Biofeedback (Healing Rhythms)
Sensors placed on fingers to capture heart rate and skin temperature

Locations

Country Name City State
United Kingdom University of Birmingham Birmingham

Sponsors (1)

Lead Sponsor Collaborator
University of Birmingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difficulties in Emotional Regulation (DERS) a 36 item self-report questionnaire developed to assess adult difficulties in emotional regulation. six specific dimensions which include; difficulties accepting emotional responses (acceptance), controlling impulse behaviours (impulse), emotional awareness (awareness), emotional clarity (clarity), assessing emotion regulation strategies (strategies) and engaging in goal oriented behaviour when emotionally aroused (goals). Internal consistency for Cronbach's alpha was .93 for the total scale and for DERS-A, .85, DERS-I, .89, DERS-A, .86, DERS-C, .80, DERS-S, .88, and DERS-G, .84 30 minutes (pre, during and post biofeedback training)
Primary Five Facet Mindfulness Questionnaire (FFMQ) Consists of 39 items assessing five facets of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Items are rated on a Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true). The FFMQ has been shown to have good internal consistency and significant relationships in the predicted directions with a variety of constructs related to mindfulness. The internal consistencies (Cronbach a) for these facets have been reported as 0.75 for FFMQ-NR, 0.83 for FFMQ-O, 0.87 for FFMQ-A, 0.91 for FFMQ-D, and 0.87 for FFMQ-NJ 30 minutes (pre, during and post biofeedback training)
Primary Becks Depression Inventory (BDI-II) A 21-item self-report scale that surveys common symptoms of depression on a 4-point scale ranging from 0 to 3. Internal consistency of the BDI-II was demonstrated to be good (Cronbach's a=.91; Beck, Steer, Ball et al., 1996) and the 1-week test-retest reliability was shown to be high. 15 minutes (pre, during and post biofeedback training)
Primary Becks Anxiety Inventory (BAI) Consists of 21 statements used to measure the severity of an individual's anxiety. When completing the BAI, individuals rate the severity of each symptom on a 4-point scale ranging from 0 (not at all) to 3 (severely—I could barely stand it). Good internal consistency (Cronbach's a=.92) and test-retest reliability (r=.75). 15 minutes (pre, during and post biofeedback training)
Secondary Heart Rate Variance (HRV) biofeedback Heart rate coherence scores were assessed using the IoM butterfly Grapher. The coherence score is based upon a composite score of 0-100%; 0 being no coherence, 100% being perfect coherence. 10 minutes per session
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04929938 - Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients N/A
Not yet recruiting NCT06133231 - Optimizing Research With Diverse Families N/A
Completed NCT05096975 - Personality Profile of Children and Adolescents With ADHD and With or Without Emotional Dysregulation
Completed NCT03846115 - A Mobile App for Peer-led Seeking Safety N/A
Completed NCT04060940 - Emotion Regulation Therapy for Clinical Worry and Rumination N/A
Recruiting NCT05076201 - Process of Regulation in Addictions: Vulnerability Emotional Factors to Craving N/A
Recruiting NCT05712057 - Neurostimulation Versus Therapy for Problems With Emotions N/A
Recruiting NCT05779761 - Brief Interventions for Coping With Distress N/A
Completed NCT04964726 - Dyadic Neurofeedback for Emotion Regulation in Youth With Maternal Adversity N/A
Active, not recruiting NCT04615416 - Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic N/A
Completed NCT04159506 - Feasibility and Acceptability Off The Equus Effect N/A
Completed NCT03603613 - Youth FORWARD Phase 1 YRI and EPP Study N/A
Recruiting NCT05734677 - Emotion Regulation Group Study N/A
Completed NCT03336827 - Improving Emotion Regulation at the End of Breast Cancer Treatment N/A
Completed NCT04280614 - Day Hospital Treatment of Emotional Dysregulation
Recruiting NCT05930886 - Focus Groups in Ethnically and Racially Diverse Families